<?xml version="1.0" encoding="UTF-8"?>
<ref id="B160-ijms-21-09461">
 <label>160.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Behan</surname>
    <given-names>F.M.</given-names>
   </name>
   <name>
    <surname>Iorio</surname>
    <given-names>F.</given-names>
   </name>
   <name>
    <surname>Picco</surname>
    <given-names>G.</given-names>
   </name>
   <name>
    <surname>Gonçalves</surname>
    <given-names>E.</given-names>
   </name>
   <name>
    <surname>Beaver</surname>
    <given-names>C.M.</given-names>
   </name>
   <name>
    <surname>Migliardi</surname>
    <given-names>G.</given-names>
   </name>
   <name>
    <surname>Santos</surname>
    <given-names>R.</given-names>
   </name>
   <name>
    <surname>Rao</surname>
    <given-names>Y.</given-names>
   </name>
   <name>
    <surname>Sassi</surname>
    <given-names>F.</given-names>
   </name>
   <name>
    <surname>Pinnelli</surname>
    <given-names>M.</given-names>
   </name>
   <etal/>
  </person-group>
  <article-title>Prioritization of Cancer Therapeutic Targets Using CRISPR–Cas9 Screens</article-title>
  <source>Nature</source>
  <year>2019</year>
  <volume>568</volume>
  <fpage>511</fpage>
  <lpage>516</lpage>
  <pub-id pub-id-type="doi">10.1038/s41586-019-1103-9</pub-id>
  <?supplied-pmid 30971826?>
  <pub-id pub-id-type="pmid">30971826</pub-id>
 </element-citation>
</ref>
